Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription 31.08.2026 1 Biochem Biophys Res Commun 1 BMC Cancer 2 Bone Marrow Transplant 1 Br J Dermatol 5 Br J Haematol 1 Eur J Haematol 1 Leuk Lymphoma 2 Leukemia 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. ZHANG X, Wen T, Chen P, Chen S, et al
   CD19 CAR-macrophage suppressed the progression of DLBCL via modulating SYK/SHP2/TBK1/TFEB signaling.
   Biochem Biophys Res Commun. 2026;832:154378.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ZHAO J, Lian J, Wen X, Ma L, et al
   Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.
   BMC Cancer. 2026;26:1018.
   PubMed        
   
   

   
   Bone Marrow Transplant

3. MANSON G, Di Blasi R, Houot R, Morschhauser F, et al
   Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
   Bone Marrow Transplant. 2026 Aug 21. doi: 10.1038/s41409-026-03001.
   PubMed         Abstract available
   
   
4. WALKER I, Deotare U, Elemary M, Elsawy M, et al
   A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study
   Bone Marrow Transplant. 2026 Aug 21. doi: 10.1038/s41409-026-03024.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

5. SCARISBRICK JJ, Geskin L, Rozati S, Morsia E, et al
   Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.
   Br J Dermatol. 2026 Aug 26:ljag266. doi: 10.1093.
   PubMed        
   
   

   
   Br J Haematol

6. BARGE L, Webb L, Pelecanos A, Waters N, et al
   LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
   Br J Haematol. 2026 Aug 27. doi: 10.1111/bjh.70748.
   PubMed         Abstract available
   
   
7. GALLAMINI A, Viviani S, Rapezzi D, Patti C, et al
   Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
   Br J Haematol. 2026 Aug 26. doi: 10.1111/bjh.70763.
   PubMed         Abstract available
   
   
8. OSBORNE W, Bielby H, Cwynarski K, El-Sharkawi D, et al
   The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.
   Br J Haematol. 2026 Aug 23. doi: 10.1111/bjh.70768.
   PubMed         Abstract available
   
   
9. QIAO X, Tang Y, Yang Q, Yuan Q, et al
   Declining treatment-related and overall mortality in children with newly diagnosed advanced-stage non-Hodgkin lymphoma treated in a paediatric cancer centre during 2013-2024, Shanghai, China.
   Br J Haematol. 2026 Aug 21. doi: 10.1111/bjh.70772.
   PubMed         Abstract available
   
   
10. JAWOREK CP, Supprian M, Brockelmann PJ, Tharmaseelan H, et al
    BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.
    Br J Haematol. 2026 Aug 21. doi: 10.1111/bjh.70771.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

11. ANTONILLI S, Marklund A, Entrop J, Dietrich CE, et al
    Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.
    Eur J Haematol. 2026 Aug 25. doi: 10.1111/ejh.70303.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

12. HAVERKOS BM, Chang C, Ristuccia R, Chang Y, et al
    Treatment utilization and outcomes in patients with mycosis fungoides and Sezary syndrome receiving mogamulizumab in community and academic practice in the United States clinical practice.
    Leuk Lymphoma. 2026;67:2035-2047.
    PubMed         Abstract available
    
    

    
    Leukemia

13. XIA C, Pradhan D, Wang W, Tang Z, et al
    Blastic plasmacytoid dendritic cell neoplasm: ontogeny, immunophenotype, genetics and epigenetics, immune dysregulation, skin tropism and therapeutic implications.
    Leukemia. 2026;40:1868-1878.
    PubMed         Abstract available
    
    
14. BEIRD HC, Kannan S, Liu J, Chen J, et al
    Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.
    Leukemia. 2026;40:1951-1960.
    PubMed         Abstract available
    
    

    
    PLoS One

15. LUQUE-BENAVIDES R, Cruz Ku G, Valcarcel B, Garcia A, et al
    Primary ocular-adnexal non-Hodgkin Lymphoma in a Peruvian cohort: An 18-year experience.
    PLoS One. 2026;21:e0356381.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

16. HILL KK, Barry AP, Reinoso-Vizcaino NM, Haynes LE, et al
    SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation.
    Proc Natl Acad Sci U S A. 2026;123:e2532225123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum